In one cancer therapy, two halves are safer than a whole
Splitting immunotoxins in half could increase their specificity toward cancers, study suggests
Splitting one type of cancer drug in half and delivering the pieces separately to cancer cells could reduce life-threatening side effects and protect healthy, non-cancerous cells, a new study suggests.